Home » Topics » Regulatory » Patents

Patents
RSS

Benzofuran smooth muscle proliferation inhibitors from Lilly

July 19, 1996

Potential hypertension treatment from Pola

July 19, 1996

NEP inhibitors described by Tanabe Seiyaku

July 19, 1996

Angiotensin II antagonists described by Kotobuki Seiyaku

July 19, 1996

5-Lipoxygenase inhibitors reported by Pfizer

July 19, 1996

Muscarinic cholinergic ligands described by Novo Nordisk

July 19, 1996

Neurogen reveals D3/D4 receptor-selective compounds

July 19, 1996

5-HT1A receptor-selective agents from American Home Products

July 19, 1996

Cholesterol absorption inhibitors from Schering-Plough

July 19, 1996

Bile acid reabsorption inhibitors described by Glaxo Wellcome

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...